Evidence map›Paper›PMID 26950706›Full record

ArticleAnesthesiology2016

Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic Receptors.

Brittney P Ciszek, Sandra C O'Buckley, Andrea G Nackley

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Anesthesiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04421209 (Analgesic Effects of Perioperative Propranolol Administration for Spine Surgery), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04421209 phase2withdrawnnot on this mapstarted 2020, after this paper: background citation

Analgesic Effects of Perioperative Propranolol Administration for Spine Surgery

TypeinterventionalSponsorDuke UniversityRan2020 to 2021Enrolled0ConditionsLumbar Disc Disease, Spinal Fusion, Degenerative Disc DiseaseArmsPropranolol Hcl 40mg Tab, Placebo oral tablet
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Journal of dental research · 2021
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sustained stimulation of βBrain, behavior, and immunity · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Brittney P CiszekFrom the Dental Research Department, Center for Pain Research and Innovation, University of North Carolina, Chapel Hill, North Carolina. Current affiliation: Center for Translational Pain Medicine, Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina (A.G.N.).
Sandra C O'Buckley
Andrea G Nackley
University of North Carolina at Chapel Hill · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Vulvar Vestibulitis syndrome (VVS)P01NS045685 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZOLNOUN, DENNIZ A · 2004 to 2014
$12.5M
Persistent COMT-dependent Pain: Role of beta-adrenergic ReceptorsR01NS072205 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NACKLEY, ANDREA G · 2011 to 2014
$1.4M
NCATS NIH HHS UL1 TR001111NCATS NIH HHS UL1TR001111NCATS NIH HHS UL1 TR002489NINDS NIH HHS P01 NS045685NINDS NIH HHS R01 NS072205
6 · The paper itself

Abstract

backgroundPatients with chronic pain disorders exhibit increased levels of catecholamines alongside diminished activity of catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines. The authors found that acute pharmacologic inhibition of COMT in rodents produces hypersensitivity to mechanical and thermal stimuli via β-adrenergic receptor (βAR) activation. The contribution of distinct βAR populations to the development of persistent pain linked to abnormalities in catecholamine signaling requires further investigation.

methodsHere, the authors sought to determine the contribution of peripheral, spinal, and supraspinal βARs to persistent COMT-dependent pain. They implanted osmotic pumps to deliver the COMT inhibitor OR486 (Tocris, USA) for 2 weeks. Behavioral responses to mechanical and thermal stimuli were evaluated before and every other day after pump implantation. The site of action was evaluated in adrenalectomized rats receiving sustained OR486 or in intact rats receiving sustained βAR antagonists peripherally, spinally, or supraspinally alongside OR486.

resultsThe authors found that male (N = 6) and female (N = 6) rats receiving sustained OR486 exhibited decreased paw withdrawal thresholds (control 5.74 ± 0.24 vs. OR486 1.54 ± 0.08, mean ± SEM) and increased paw withdrawal frequency to mechanical stimuli (control 4.80 ± 0.22 vs. OR486 8.10 ± 0.13) and decreased paw withdrawal latency to thermal heat (control 9.69 ± 0.23 vs. OR486 5.91 ± 0.11). In contrast, adrenalectomized rats (N = 12) failed to develop OR486-induced hypersensitivity. Furthermore, peripheral (N = 9), but not spinal (N = 4) or supraspinal (N = 4), administration of the nonselective βAR antagonist propranolol, the β2AR antagonist ICI-118,511, or the β3AR antagonist SR59230A blocked the development of OR486-induced hypersensitivity.

conclusionsPeripheral adrenergic input is necessary for the development of persistent COMT-dependent pain, and peripherally-acting βAR antagonists may benefit chronic pain patients.

Indexed as

AdrenalectomyAdrenergic beta-AntagonistsAnimalsBehavior, AnimalCatechol O-MethyltransferaseCatechol O-Methyltransferase InhibitorsCatecholsFemaleHot TemperatureInjections, SpinalMalePainPain MeasurementPeripheral Nervous SystemPhysical StimulationPropanolamines3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalateAdrenergic beta-AntagonistsCatechol O-MethyltransferaseCatechol O-Methyltransferase InhibitorsCatecholsICI 118551OR486PropanolaminesReceptors, Adrenergic, beta

Identifiers

PMID26950706
PMCPMC5015695
OpenAlexW2293175887

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.